126 related articles for article (PubMed ID: 10025369)
1. Concomitant chemotherapy and reirradiation as management for recurrent cancer of the head and neck.
Spencer SA; Wheeler RH; Peters GE; Beenken SW; Meredith RF; Smith J; Conner W; Salter MM
Am J Clin Oncol; 1999 Feb; 22(1):1-5. PubMed ID: 10025369
[TBL] [Abstract][Full Text] [Related]
2. Phase 1 trial of combined chemotherapy and reirradiation for recurrent unresectable head and neck cancer.
Spencer S; Wheeler R; Peters G; Meredith R; Beenken S; Nabel L; Wooten A; Soong SJ; Salter M
Head Neck; 2003 Feb; 25(2):118-22. PubMed ID: 12509794
[TBL] [Abstract][Full Text] [Related]
3. Recurrent head and neck cancer: retreatment of previously irradiated areas with combined chemotherapy and radiation therapy-results of a prospective study.
Schaefer U; Micke O; Schueller P; Willich N
Radiology; 2000 Aug; 216(2):371-6. PubMed ID: 10924555
[TBL] [Abstract][Full Text] [Related]
4. Treatment of recurrent head and neck cancer with 5-fluorouracil, hydroxyurea, and reirradiation.
Weppelmann B; Wheeler RH; Peters GE; Kim RY; Spencer SA; Meredith RF; Salter MM
Int J Radiat Oncol Biol Phys; 1992; 22(5):1051-6. PubMed ID: 1555952
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma.
Salama JK; Vokes EE; Chmura SJ; Milano MT; Kao J; Stenson KM; Witt ME; Haraf DJ
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):382-91. PubMed ID: 16213104
[TBL] [Abstract][Full Text] [Related]
6. Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer.
Machtay M; Rosenthal DI; Chalian AA; Lustig R; Hershock D; Miller L; Weinstein GS; Weber RS
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):72-7. PubMed ID: 15093901
[TBL] [Abstract][Full Text] [Related]
7. Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients.
De Crevoisier R; Bourhis J; Domenge C; Wibault P; Koscielny S; Lusinchi A; Mamelle G; Janot F; Julieron M; Leridant AM; Marandas P; Armand JP; Schwaab G; Luboinski B; Eschwege F
J Clin Oncol; 1998 Nov; 16(11):3556-62. PubMed ID: 9817275
[TBL] [Abstract][Full Text] [Related]
8. Paclitaxel, 5-fluorouracil, hydroxyurea, and concomitant radiation therapy for poor-prognosis head and neck cancer.
Vokes EE; Haraf DJ; Brockstein BE; Weichselbaum RR
Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):70-6. PubMed ID: 10210543
[TBL] [Abstract][Full Text] [Related]
9. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
10. Full dose reirradiation combined with chemotherapy after salvage surgery in head and neck carcinoma.
De Crevoisier R; Domenge C; Wibault P; Koscielny S; Lusinchi A; Janot F; Bobin S; Luboinski B; Eschwege F; Bourhis J
Cancer; 2001 Jun; 91(11):2071-6. PubMed ID: 11391587
[TBL] [Abstract][Full Text] [Related]
11. RTOG 96-10: reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck.
Spencer SA; Harris J; Wheeler RH; Machtay M; Schultz C; Spanos W; Rotman M; Meredith R
Int J Radiat Oncol Biol Phys; 2001 Dec; 51(5):1299-304. PubMed ID: 11728690
[TBL] [Abstract][Full Text] [Related]
12. Hydroxyurea, fluorouracil, and concomitant radiotherapy in poor-prognosis head and neck cancer: a phase I-II study.
Vokes EE; Panje WR; Schilsky RL; Mick R; Awan AM; Moran WJ; Goldman MD; Tybor AG; Weichselbaum RR
J Clin Oncol; 1989 Jun; 7(6):761-8. PubMed ID: 2715806
[TBL] [Abstract][Full Text] [Related]
13. Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: a potentially curable disease.
Haraf DJ; Weichselbaum RR; Vokes EE
Ann Oncol; 1996 Nov; 7(9):913-8. PubMed ID: 9006741
[TBL] [Abstract][Full Text] [Related]
14. Chemo-reirradiation in persistent/recurrent head and neck cancers.
Nagar YS; Singh S; Datta NR
Jpn J Clin Oncol; 2004 Feb; 34(2):61-8. PubMed ID: 15067097
[TBL] [Abstract][Full Text] [Related]
15. Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy.
Milano MT; Vokes EE; Salama JK; Stenson KM; Kao J; Witt ME; Mittal BB; Argiris A; Weichselbaum RR; Haraf DJ
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1096-106. PubMed ID: 15752889
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911.
Langer CJ; Harris J; Horwitz EM; Nicolaou N; Kies M; Curran W; Wong S; Ang K
J Clin Oncol; 2007 Oct; 25(30):4800-5. PubMed ID: 17947728
[TBL] [Abstract][Full Text] [Related]
17. Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck.
Spencer SA; Harris J; Wheeler RH; Machtay M; Schultz C; Spanos W; Rotman M; Meredith R; Ang KK
Head Neck; 2008 Mar; 30(3):281-8. PubMed ID: 17764087
[TBL] [Abstract][Full Text] [Related]
18. Radiation therapy with concomitant hydroxyurea and fluorouracil in stage II and III head and neck cancer.
Haraf DJ; Kies M; Rademaker AW; Stenson K; Mittal B; Pelzer H; Wenig B; Witt ME; Sulzen L; Weichselbaum RR; Vokes EE
J Clin Oncol; 1999 Feb; 17(2):638-44. PubMed ID: 10080609
[TBL] [Abstract][Full Text] [Related]
19. Intensified concomitant chemoradiotherapy with and without filgrastim for poor-prognosis head and neck cancer.
Vokes EE; Haraf DJ; Mick R; McEvilly JM; Weichselbaum RR
J Clin Oncol; 1994 Nov; 12(11):2351-9. PubMed ID: 7525886
[TBL] [Abstract][Full Text] [Related]
20. Phase I study of concomitant chemoradiotherapy with irinotecan, 5-FU, and hydroxyurea for patients with advanced and/or recurrent head and neck cancer.
Salama JK; Haraf DJ; Stenson K; Milano MT; Witt ME; Vokes EE
Cancer J; 2005; 11(2):140-6. PubMed ID: 15969989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
